RBC Life Sciences, Inc.
RBC Life Sciences, Inc., a prominent player in the biotechnology and life sciences sector, is headquartered in the United States. Founded in 1997, the company has established itself as a leader in the development and distribution of innovative health products, particularly in the fields of nutritional supplements and diagnostic testing. With a focus on enhancing health and wellness, RBC Life Sciences offers a unique range of core products, including proprietary formulations that cater to various health needs. The company’s commitment to quality and scientific research has positioned it favourably in the competitive life sciences market. Notable achievements include significant advancements in product efficacy and a growing presence in key operational regions across North America.
DitchCarbon Score
How does RBC Life Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RBC Life Sciences, Inc.'s score of 29 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RBC Life Sciences, Inc.'s reported carbon emissions
RBC Life Sciences, Inc., headquartered in the US, currently does not report specific carbon emissions data. However, the company has established significant climate commitments aimed at reducing its carbon footprint. For Scope 1 emissions, RBC Life Sciences is targeting a reduction of approximately 36% by 2030, compared to 2020 levels. This commitment aligns with broader trends in developed economies, including the EU and the US, which are also pursuing similar reduction targets. In terms of Scope 2 emissions, RBC Life Sciences has set an identical target of about 36% reduction by 2030, again relative to 2020 levels. Looking towards the long term, the company has committed to achieving net-zero emissions for both Scope 1 and Scope 2 by 2060. This commitment reflects a growing trend among companies to align with global climate goals, particularly as many emerging economies have set ambitious targets extending beyond 2050. Overall, while specific emissions data is not available, RBC Life Sciences is actively working towards substantial reductions in its carbon emissions through defined targets for both near-term and long-term sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RBC Life Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
